| Knowledge4COVID-19

Property	Value
is ?:annotates of	<https://research.tib.eu/covid-19/entity/32489023_HAS_TOPIC_C0003062> <https://research.tib.eu/covid-19/entity/32489023_HAS_TOPIC_C0024109> <https://research.tib.eu/covid-19/entity/32489023_HAS_TOPIC_C0025914> <https://research.tib.eu/covid-19/entity/32489023_HAS_TOPIC_C0025919> <https://research.tib.eu/covid-19/entity/32489023_HAS_TOPIC_C0025929> <https://research.tib.eu/covid-19/entity/32489023_HAS_TOPIC_C0026809> <https://research.tib.eu/covid-19/entity/32489023_HAS_TOPIC_C0032310> <https://research.tib.eu/covid-19/entity/32489023_HAS_TOPIC_C0162416> <https://research.tib.eu/covid-19/entity/32489023_HAS_TOPIC_C0206750> <https://research.tib.eu/covid-19/entity/32489023_HAS_TOPIC_C0751318> <https://research.tib.eu/covid-19/entity/32489023_HAS_TOPIC_C1615608> <https://research.tib.eu/covid-19/entity/32489023_HAS_TOPIC_C2713498> <https://research.tib.eu/covid-19/entity/32489023_HAS_TOPIC_C3694279> <https://research.tib.eu/covid-19/entity/32489023_HAS_TOPIC_C5203670> <https://research.tib.eu/covid-19/entity/32489023_HAS_TOPIC_C5203676> <https://research.tib.eu/covid-19/entity/32489023_HAS_TOPIC_C5392141>
?:authorAffiliation	[\'Institute of Chinese Materia Medica, China Academy of Chinese Medical Sciences Beijing 100700, China.\', \'Heilongjiang ZBD Pharmaceutical Co., Ltd. Harbin 158400, China.\']
?:citedBy	-1
?:creator	<https://research.tib.eu/covid-19/entity/Bao_Lei> <https://research.tib.eu/covid-19/entity/Bao_Yan-Yan> <https://research.tib.eu/covid-19/entity/Cui_Xiao-Lan> <https://research.tib.eu/covid-19/entity/Fang_Tong-Hua> <https://research.tib.eu/covid-19/entity/Gao_Ying-Jie> <https://research.tib.eu/covid-19/entity/Geng_Zi-Han> <https://research.tib.eu/covid-19/entity/Guo_Shan-Shan> <https://research.tib.eu/covid-19/entity/Meng_Jie> <https://research.tib.eu/covid-19/entity/Shi_Yu-Jing> <https://research.tib.eu/covid-19/entity/Sun_Jing> <https://research.tib.eu/covid-19/entity/Zhao_Rong-Hua>
?:doi	<https://research.tib.eu/covid-19/entity/10.19540/j.cnki.cjcmm.20200303.402>
?:doi	10.19540/j.cnki.cjcmm.20200303.402
?:hasPublicationType	<https://research.tib.eu/covid-19/entity/Journal_Article>
?:journal	Zhongguo Zhong yao za zhi = Zhongguo zhongyao zazhi = China journal of Chinese materia medica
is ?:pmid of	<https://research.tib.eu/covid-19/entity/32489023> <https://research.tib.eu/covid-19/entity/8vdt2ibe>
?:pmid	<https://research.tib.eu/covid-19/entity/32489023>
?:pmid	32489023
?:publication_isRelatedTo_Disease	<https://research.tib.eu/covid-19/entity/Covid-19>
?:rankingScore_SJR	-1.0
?:rankingScore_hIndex	-1
is ?:relation_isRelatedTo_publication of	<https://research.tib.eu/covid-19/entity/C0012634_PROCESS_OF_C0025919> <https://research.tib.eu/covid-19/entity/C0012634_PROCESS_OF_C0026809> <https://research.tib.eu/covid-19/entity/C0032285_PROCESS_OF_C0206422> <https://research.tib.eu/covid-19/entity/C0039082_COEXISTS_WITH_C0011900> <https://research.tib.eu/covid-19/entity/C0039082_PROCESS_OF_C0025919> <https://research.tib.eu/covid-19/entity/C0039082_PROCESS_OF_C0026809> <https://research.tib.eu/covid-19/entity/C2948600_TREATS_C0032285>
?:title	[Therapeutic effect of Compound Qinlan Oral Liquid on treating combining disease with syndrome of human coronavirus pneumonia with pestilence attacking lung syndrome].
?:type	<https://research.tib.eu/covid-19/vocab/Publication> <https://research.tib.eu/covid-19/vocab/Publication_Author>
?:year	2020

Metadata

Anon_0

<http://www.w3.org/1999/02/22-rdf-syntax-ns#type>

<http://purl.org/net/provenance/ns#DataItem>

<http://www.w3.org/1999/02/22-rdf-syntax-ns#type>

<http://www.w3.org/2004/03/trix/rdfg-1/Graph>

<http://xmlns.com/foaf/0.1/primaryTopic>

<https://research.tib.eu/covid-19/entity/32489023>

<http://xmlns.com/foaf/0.1/topic>

Anon_0

<http://www.ontologydesignpatterns.org/cp/owl/informationrealization.owl#realizes>

<https://research.tib.eu/covid-19/data/entity/32489023>

<http://purl.org/net/provenance/ns#createdBy>

Anon_1 (more)

expand all